MOUNTAIN VIEW, Calif., Aug. 15, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure ® procedure, the leading surgery-free permanent birth control method, announced today that Company management is planning to participate in the following investor conferences:
- The Stifel Nicolaus 2012 Healthcare Conference on Wednesday, September 5, 2012, in Boston, Massachusetts. A live webcast of the Company presentation will take place at 2:40 p.m. Eastern time and will be available on the Company's website at www.conceptus.com . When accessing the live webcast, select "Investors" then select "Events and Presentations." An archived replay will be available following the live presentation.
- The Fifth Annual Barrington Research Growth Conference on Thursday, September 6, 2012, in Chicago, Illinois. There will be no webcast presentation.
- The 3rd Annual Medical Technology 1X1 Corporate Access Day on Tuesday, September 18, 2012, in Boston, Massachusetts. There will be no webcast presentation.
About Conceptus ®, Inc.Conceptus, Inc. is the leader in the development of innovative device-based solutions in permanent birth control. The Company manufactures and markets the Essure procedure. The Essure procedure is available in the United States, Europe, Australia, New Zealand, Canada, Mexico, Central and South America and the Middle East. Please visit www.essure.com for more information on the Essure procedure. Patients may call the Essure Information Center at 1-877-ESSURE-1 with questions or to find a physician in their area. The Conceptus, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7961 © 2012 Conceptus, Inc.— All rights reserved.
CONTACT: Investor and Public Relations Contact: Cindy Klimstra (650) 962-4032 firstname.lastname@example.org